Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial | RemedyX Labs Research Library

A research summary of Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial, covering Semaglutide (RXL-1SM) in the context of randomized cardiovascular-outcomes trial analysis research. Cited source and RUO context from RemedyX Labs.